Cargando…

The Inhibitory Properties of a Novel, Selective LMTK3 Kinase Inhibitor

Recently, the oncogenic role of lemur tyrosine kinase 3 (LMTK3) has been well established in different tumor types, highlighting it as a viable therapeutic target. In the present study, using in vitro and cell-based assays coupled with biophysical analyses, we identify a highly selective small molec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Agnarelli, Alessandro, Lauer Betrán, Andrea, Papakyriakou, Athanasios, Vella, Viviana, Samuels, Mark, Papanastasopoulos, Panagiotis, Giamas, Christina, Mancini, Erika J., Stebbing, Justin, Spencer, John, Cilibrasi, Chiara, Ditsiou, Angeliki, Giamas, Georgios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821308/ https://www.ncbi.nlm.nih.gov/pubmed/36614307 http://dx.doi.org/10.3390/ijms24010865

Ejemplares similares

LMTK3 inhibition affects microtubule stability
por: Cilibrasi, Chiara, et al.
Publicado: (2021)

Correction to: LMTK3 inhibition affects microtubule Stability
por: Cilibrasi, Chiara, et al.
Publicado: (2021)

Incorporating Immunotherapy in the Management of Gastric Cancer: Molecular and Clinical Implications
por: Agnarelli, Alessandro, et al.
Publicado: (2022)

Lemur tyrosine kinase-3 (LMTK3) in cancer and evolution
por: Stebbing, Justin, et al.
Publicado: (2011)

Reconstituting Immune Surveillance in Breast Cancer: Molecular Pathophysiology and Current Immunotherapy Strategies
por: Cilibrasi, Chiara, et al.
Publicado: (2021)

Extracellular Vesicles as Mediators of Therapy Resistance in the Breast Cancer Microenvironment
por: Samuels, Mark, et al.
Publicado: (2022)

The structure-function relationship of oncogenic LMTK3
por: Ditsiou, Angeliki, et al.
Publicado: (2020)

The multifaceted role of lemur tyrosine kinase 3 in health and disease
por: Ditsiou, Angeliki, et al.
Publicado: (2021)

LMTK3 confers chemo-resistance in breast cancer
por: Stebbing, Justin, et al.
Publicado: (2018)

EGF and IGF1 affect sunitinib activity in BP-NEN: new putative targets beyond VEGFR?
por: Bresciani, Giulia, et al.
Publicado: (2019)

The many-faced KSR1: a tumor suppressor in breast cancer
por: Zhang, Hua, et al.
Publicado: (2015)

Proteome-wide dataset supporting functional study of tyrosine kinases in breast cancer
por: Angelopoulos, Nicos, et al.
Publicado: (2016)

Endocrine Resistance in Hormone Receptor Positive Breast Cancer–From Mechanism to Therapy
por: Rani, Aradhana, et al.
Publicado: (2019)

PDGF-R inhibition induces glioblastoma cell differentiation via DUSP1/p38(MAPK) signalling
por: Lane, Rosemary, et al.
Publicado: (2022)

Characterization of the Tyrosine Kinase-Regulated Proteome in Breast Cancer by Combined use of RNA interference (RNAi) and Stable Isotope Labeling with Amino Acids in Cell Culture (SILAC) Quantitative Proteomics
por: Stebbing, Justin, et al.
Publicado: (2015)

Definition of an Inflammatory Biomarker Signature in Plasma-Derived Extracellular Vesicles of Glioblastoma Patients
por: Cilibrasi, Chiara, et al.
Publicado: (2022)

Proteomic profile of KSR1-regulated signalling in response to genotoxic agents in breast cancer
por: Zhang, Hua, et al.
Publicado: (2015)

A Prediction Model Using Alternative Splicing Events and the Immune Microenvironment Signature in Lung Adenocarcinoma
por: Zhu, Liping, et al.
Publicado: (2021)

SILAC-based phosphoproteomics reveals an inhibitory role of KSR1 in p53 transcriptional activity via modulation of DBC1
por: Zhang, H, et al.
Publicado: (2013)

ATG9A loss confers resistance to trastuzumab via c-Cbl mediated Her2 degradation
por: Nunes, Joao, et al.
Publicado: (2016)

A Pan-Cancer Analysis of SMARCA4 Alterations in Human Cancers
por: Peng, Ling, et al.
Publicado: (2021)

Cancer gene therapy 2020: highlights from a challenging year
por: Giamas, Georgios, et al.
Publicado: (2021)

The role of non-coding RNAs in extracellular vesicles in breast cancer and their diagnostic implications
por: Samuels, Mark, et al.
Publicado: (2023)

Shooting the messenger: a systematic review investigating extracellular vesicle isolation and characterisation methods and their influence on understanding extracellular vesicles-radiotherapy interactions in glioblastoma
por: Robinson, Stephen David, et al.
Publicado: (2023)

Shedding of bevacizumab in tumour cells-derived extracellular vesicles as a new therapeutic escape mechanism in glioblastoma
por: Simon, Thomas, et al.
Publicado: (2018)

Targeting lemurs against cancer metastasis
por: Xu, Yichen, et al.
Publicado: (2014)

Breaking through the glioblastoma micro-environment via extracellular vesicles
por: Simon, Thomas, et al.
Publicado: (2020)

Mastering MongoDB 4.x: expert techniques to run high-volume and fault-tolerant database solutions using MongoDB 4.x
por: Giamas, Alex
Publicado: (2019)

Mastering MongoDB 3.x: an expert's guide to building fault-tolerant MongoDB applications
por: Giamas, Alex
Publicado: (2017)

A prognostic model of drug tolerant persister-related genes in lung adenocarcinoma based on single cell and bulk RNA sequencing data
por: Du, Zhonghai, et al.
Publicado: (2023)

CK1δ modulates the transcriptional activity of ERα via AIB1 in an estrogen-dependent manner and regulates ERα–AIB1 interactions
por: Giamas, Georgios, et al.
Publicado: (2009)

Hyperactive and impulsive behaviors of LMTK1 knockout mice
por: Takahashi, Miyuki, et al.
Publicado: (2020)

Three Method-Combination Protocol for Improving Purity of Extracellular Vesicles
por: Simon, Thomas, et al.
Publicado: (2020)

Biological function of Lemur tyrosine kinase 2 (LMTK2): implications in neurodegeneration
por: Bencze, János, et al.
Publicado: (2018)

Cell-derived extracellular vesicles can be used as a biomarker reservoir for glioblastoma tumor subtyping
por: Lane, Rosemary, et al.
Publicado: (2019)

LMTK1, a Novel Modulator of Endosomal Trafficking in Neurons
por: Hisanaga, Shin-ichi, et al.
Publicado: (2020)

MicroRNAs Targeting Oncogenes Are Down-Regulated in Pancreatic Malignant Transformation from Benign Tumors
por: Jiao, Long R., et al.
Publicado: (2012)

MSLN Gene Silencing Has an Anti-Malignant Effect on Cell Lines Overexpressing Mesothelin Deriving from Malignant Pleural Mesothelioma
por: Melaiu, Ombretta, et al.
Publicado: (2014)

Correction: MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma
por: Melaiu, Ombretta, et al.
Publicado: (2017)

LMTK2 binds to kinesin light chains to mediate anterograde axonal transport of cdk5/p35 and LMTK2 levels are reduced in Alzheimer’s disease brains
por: Mórotz, Gábor M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ksu83vts9aqecac5fi0nkn2ivn